Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Sosei Group Corp

+ Add to Watchlist

4565:JP

3,345.0 JPY 45.0 1.33%

As of 01:00:00 ET on 02/27/2015.

Snapshot for Sosei Group Corp (4565)

Open: 3,430.0 Day's Range: 3,320.0 - 3,490.0 Volume: 375,100
Previous Close: 3,390.0 52wk Range: 1,854.0 - 6,000.0 1-Yr Rtn: +19.59%

Stock Chart for 4565

No chart data available.
  • 4565:JP 3,330.0
  • 1D
  • 1M
  • 1Y
3,390.0
Interactive 4565 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4565

Current P/E Ratio (ttm) 79.9532
Estimated P/E(03/2015) 19.3576
Relative P/E vs. TPX 4.6124
Earnings Per Share (JPY) (ttm) 41.8370
Est. EPS (JPY) (03/2015) 172.8000
Est. PEG Ratio -
Market Cap (M JPY) 46,074.03
Shares Outstanding (M) 13.77
30 Day Average Volume 251,583
Price/Book (mrq) 3.0600
Price/Sale (ttm) 38.5195
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4565

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4565

Sosei Group Corporation is a holding company which was established through reorganization. The Group companies are biopharmaceutical companies specializing in drug development. Sosei Group enters into license agreements primarily with US, EU, and Japanese companies to market the licensed drugs in Japan and find alternative usage on such drugs.

Shinichi TamuraPresident/CEOAkinori MochizukiExecutive Vice President/CSO
Hidetoshi ToramiExecutive Vice President/CFOHiromu OzakiExecutive Vice President
More Company Profile & Key Executives for 4565

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil